Rethink Your Drinking
Do you drink alcohol heavily? Looking to cut back or stop?
Do you have a friend, family member, or loved one who needs to cut down?
Researchers at the University of Maryland School of Medicine are conducting a study of an investigational medication for the treatment of heavy drinking.
The goal of this 14-week research study is to determine the impact of a medication called pregabalin in reducing heavy drinking and symptoms of post-traumatic stress disorder (PTSD). The study will also look at the safety and tolerability of pregabalin in participants with alcohol-use disorder and co-occurring PTSD.
Who May Participate in this Study
We are looking for individuals who are:
- Adults 18-65 years of age
- Of African-American descent
- Have experienced trauma at some point
- In good physical health
Participants will have a screening visit to see if they are eligible. Those who are eligible are asked to complete weekly study visits for an additional 12 weeks that include taking study medication, providing information about drinking and PTSD symptoms, and completing a brief educational meeting.
Participants will be compensated for their time. Assistance with transportation is available.
Learn more about this opportunity by visiting its clinicaltrials.gov website (ClinicalTrials.gov ID: NCT02884908).
To learn more about PTSD, pregabalin and what is considered heavy drinking, please visit our Definitions webpage.
Dr. Bankole Johnson discusses an investigational medication for the treatment of heavy drinking.
For More Information
To learn more about the study or to participate, you may contact us any of the following ways:
All calls are confidential.